These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6094098)

  • 21. Inhibitors of angiotensin-converting enzyme.
    Cushman DW; Ondetti MA
    Prog Med Chem; 1980; 17():41-104. PubMed ID: 6273970
    [No Abstract]   [Full Text] [Related]  

  • 22. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
    Case DB; Wallace JM; Keim HJ; Weber MA; Drayer JI; White RP; Sealey JE; Laragh JH
    Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of the renin-angiotensin system in heart failure.
    Kim SD
    Biol Res Nurs; 2000 Jan; 1(3):210-26. PubMed ID: 11232216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease.
    Kobori H; Nangaku M; Navar LG; Nishiyama A
    Pharmacol Rev; 2007 Sep; 59(3):251-87. PubMed ID: 17878513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Angiotensin-converting enzyme inhibitors as first choice drugs in chronic congestive heart failure].
    Adamska-Dyniewska H
    Pol Arch Med Wewn; 1992; 88(2-3):165-70. PubMed ID: 1337204
    [No Abstract]   [Full Text] [Related]  

  • 26. Renin-angiotensin role in thirst: paradoxical enhancement of drinking by angiotensin converting enzyme inhibitor.
    Lehr D; Goldman HW; Casner P
    Science; 1973 Dec; 182(4116):1031-4. PubMed ID: 4356029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of renin-angiotensin system in chronic renal hypertensive rats.
    Sen S; Smeby RR; Bumpus FM; Turcotte JG
    Hypertension; 1979; 1(4):427-34. PubMed ID: 232087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin II and its receptors in the diabetic kidney.
    Burns KD
    Am J Kidney Dis; 2000 Sep; 36(3):449-67. PubMed ID: 10977776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The brain renin angiotensin system in central cardiovascular control.
    Ganten D; Paul M; Deboben A; Unger T; Lang RE
    Contrib Nephrol; 1984; 43():114-28. PubMed ID: 6207981
    [No Abstract]   [Full Text] [Related]  

  • 30. Circulatory basis for the use of angiotensin converting enzyme inhibitors in hypertension and cardiac failure.
    Robertson JI
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S2-8. PubMed ID: 2422488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of mineralocorticoid receptor gene disruption on the components of the renin-angiotensin system in 8-day-old mice.
    Hubert C; Gasc JM; Berger S; Schütz G; Corvol P
    Mol Endocrinol; 1999 Feb; 13(2):297-306. PubMed ID: 9973259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Editorial: Angiotensin inhibition.
    Chobanian AV
    N Engl J Med; 1974 Oct; 291(16):844-5. PubMed ID: 4371423
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacology of angiotensin converting enzyme inhibitors. A review.
    Nelson EB; Pool JL; Taylor AA
    Am J Med; 1986 Oct; 81(4C):13-8. PubMed ID: 3022580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The tonin-angiotensin II system].
    Boucher R; Demassieux S; Garcia R; Gutkowska Y; Genest J
    Union Med Can; 1977 Apr; 106(4):502-7. PubMed ID: 193229
    [No Abstract]   [Full Text] [Related]  

  • 35. The renin-angiotensin system in the heart and vascular wall: new therapeutic aspects.
    Falkenhahn M; Gohlke P; Paul M; Stoll M; Unger T
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S6-13. PubMed ID: 7898096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure.
    Jorde UP; Ennezat PV; Lisker J; Suryadevara V; Infeld J; Cukon S; Hammer A; Sonnenblick EH; Le Jemtel TH
    Circulation; 2000 Feb; 101(8):844-6. PubMed ID: 10694521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renin-angiotensin system in human failing hearts: message from nonmyocyte cells to myocytes.
    Matsubara H
    Circ Res; 2001 May; 88(9):861-3. PubMed ID: 11348994
    [No Abstract]   [Full Text] [Related]  

  • 38. Angiotensin I-converting enzyme genotypes and angiotensin II receptors. Response to therapy.
    Dieguez-Lucena JL; Aranda-Lara P; Ruiz-Galdón M; García-Villanova J; Morell-Ocaña M; Reyes-Engel A
    Hypertension; 1996 Jul; 28(1):98-103. PubMed ID: 8675271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue renin-angiotensin systems and their modulation: the heart as a paradigm for new aspects of converting enzyme inhibition.
    Lindpaintner K; Ganten D
    Cardiology; 1991; 79 Suppl 1():32-44. PubMed ID: 1655263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antihypertensive properties of a new long-acting angiotensin converting enzyme inhibitor in renin-dependent and independent hypertensive models.
    Nagata S; Takeyama K; Fukuya F; Nagai R; Hosoki K; Nishimura K; Deguchi T; Karasawa T
    Arzneimittelforschung; 1995 Aug; 45(8):853-8. PubMed ID: 7575746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.